You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.


Test Information
Home / Tests / Critical Infectious Diseases / Xpert MTB/RIF

Xpert® MTB/RIF

Two-hour detection of MTB and rifampin resistance mutations

Ordering Info
Xpert<sup>®</sup> MTB/RIF

The Need

Great challenges face the global community, including the United States, with the worldwide re-emergence of TB and increased number of multi-drug resistant TB (MDR-TB) cases. The need for fast and accurate TB diagnosis with indication for the drug resistance is greater than ever.

Current MTB diagnostics methods require weeks to deliver a definitive result. Delayed results reporting can lead to patients placed in respiratory isolation unnecessarily or put on ineffective therapies. AFB smear could provide faster turn-around time, but may be missing the true positive cases and patients may continue to spread MTB to others in the community, increasing the disease burden.

The Solution

Xpert MTB/RIF, on-demand molecular testing — an ideal solution:

  • On-demand results that empowers physicians to manage patients effectively
  • As few as one negative result can be used in the decision to remove patient from respiratory isolation
  • Simultaneous detection of both MTB and rifampin resistance mutations, which are markers for MDR-TB strain
  • Acceptable samples include raw or concentrated sediments prepared from induced or expectorated sputum

The Impact

/Site Images/Tests/mtbrif-pathway-updated.png

Impact on Patient Isolation Pathway*

* Refer to the Xpert MTB/RIF package insert for details
^ Example with one Xpert® MTB/RIF negative result
# MOTT: Mycobacteria Other Than Tuberculosis; DST: Drug Susceptibly Test

Ordering Info

Xpert® MTB/RIF

Standard 10-Test Kit: GXMTB/RIF-US-10

Back to Top